Role of rituximab in the treatment of postpartum acquired haemophilia A: a systematic review of the literature.
作者信息
Bonfanti Carlo, Crestani Silvia, Frattini Francesco, Sissa Cinzia, Franchini Massimo
机构信息
Department of Transfusion Medicine and Haematology, "Carlo Poma" Hospital, Mantua, Italy.
出版信息
Blood Transfus. 2015 Jul;13(3):396-400. doi: 10.2450/2014.0242-14. Epub 2014 Dec 17.
Abstract
摘要
相似文献
1
Role of rituximab in the treatment of postpartum acquired haemophilia A: a systematic review of the literature.利妥昔单抗在产后获得性甲型血友病治疗中的作用：文献系统评价
Blood Transfus. 2015 Jul;13(3):396-400. doi: 10.2450/2014.0242-14. Epub 2014 Dec 17.
2
Rituximab for eradicating inhibitors in people with acquired haemophilia A.利妥昔单抗用于清除获得性甲型血友病患者体内的抑制物。
Cochrane Database Syst Rev. 2016 Jul 8;7(7):CD011907. doi: 10.1002/14651858.CD011907.pub2.
3
Acquired haemophilia A in the postpartum and risk of relapse in subsequent pregnancies: A systematic literature review.产后获得性血友病 A 及其在后续妊娠中复发的风险：系统文献综述。
Haemophilia. 2021 Mar;27(2):199-210. doi: 10.1111/hae.14233. Epub 2021 Feb 6.
4
Rituximab for eradicating inhibitors in people with acquired haemophilia A.利妥昔单抗治疗获得性血友病 A 患者的抑制剂
Cochrane Database Syst Rev. 2021 Aug 23;8(8):CD011907. doi: 10.1002/14651858.CD011907.pub3.
5
Inhibitor Eradication in Postpartum Acquired Haemophilia A: Real-Life Case Series and Literature Review.产后获得性甲型血友病中抑制剂的清除：真实病例系列及文献综述
Haemophilia. 2025 May;31(3):494-501. doi: 10.1111/hae.70020. Epub 2025 Mar 7.
6
Rituximab for treating inhibitors in people with inherited severe hemophilia.利妥昔单抗用于治疗遗传性重度血友病患者的抑制剂。
Cochrane Database Syst Rev. 2017 Jul 7;7(7):CD010810. doi: 10.1002/14651858.CD010810.pub3.
7
Rituximab in the treatment of adult acquired hemophilia A: a systematic review.
Crit Rev Oncol Hematol. 2007 Jul;63(1):47-52. doi: 10.1016/j.critrevonc.2006.11.004. Epub 2007 Jan 19.
8
Efficacy of rituximab treatment in postpartum acquired haemophilia A.利妥昔单抗治疗产后获得性甲型血友病的疗效
Haemophilia. 2008 Jan;14(1):147-9. doi: 10.1111/j.1365-2516.2007.01587.x. Epub 2007 Oct 22.
9
Immune tolerance with rituximab in congenital haemophilia with inhibitors: a systematic literature review based on individual patients' analysis.利妥昔单抗在先天性血友病伴抑制物患者中的免疫耐受：基于个体患者分析的系统文献综述
Haemophilia. 2008 Sep;14(5):903-12. doi: 10.1111/j.1365-2516.2008.01839.x. Epub 2008 Jul 28.
10
Lessons from a systematic literature review of the effectiveness of recombinant factor VIIa in acquired haemophilia.从一项关于重组因子 VIIa 在获得性血友病中有效性的系统文献回顾中得到的经验教训。
Ann Hematol. 2018 Oct;97(10):1889-1901. doi: 10.1007/s00277-018-3372-z. Epub 2018 May 26.
引用本文的文献
1
Acquired Hemophilia A: A Rare, Acquired Coagulopathy in the Postpartum Setting.
AJP Rep. 2023 Nov 28;13(4):e85-e88. doi: 10.1055/a-2198-7888. eCollection 2023 Jul.
2
Acquired Haemophilia A: A 15-Year Single-Centre Experience of Demography, Clinical Features and Outcome.获得性血友病A：一项关于人口统计学、临床特征及结局的15年单中心经验
J Clin Med. 2022 May 11;11(10):2721. doi: 10.3390/jcm11102721.
3
Rituximab for eradicating inhibitors in people with acquired haemophilia A.利妥昔单抗治疗获得性血友病 A 患者的抑制剂
Cochrane Database Syst Rev. 2021 Aug 23;8(8):CD011907. doi: 10.1002/14651858.CD011907.pub3.
4
Clinical characteristics and outcomes of acquired hemophilia A: experience at a single center in Japan.获得性血友病A的临床特征与转归：日本单中心经验
Int J Hematol. 2017 Jul;106(1):82-89. doi: 10.1007/s12185-017-2210-8. Epub 2017 Mar 15.
5
Rituximab for eradicating inhibitors in people with acquired haemophilia A.利妥昔单抗用于清除获得性甲型血友病患者体内的抑制物。
Cochrane Database Syst Rev. 2016 Jul 8;7(7):CD011907. doi: 10.1002/14651858.CD011907.pub2.
本文引用的文献
1
Inhibitor eradication with rituximab in haemophilia: where do we stand?利妥昔单抗在血友病中清除抑制剂：我们处于什么位置？
Br J Haematol. 2014 Jun;165(5):600-8. doi: 10.1111/bjh.12829. Epub 2014 Mar 15.
2
Acquired haemophilia A: a 2013 update.获得性血友病 A：2013 年更新。
Thromb Haemost. 2013 Dec;110(6):1114-20. doi: 10.1160/TH13-05-0363. Epub 2013 Sep 5.
3
Therapeutic challenges in acquired factor VIII deficiency.获得性因子 VIII 缺乏症的治疗挑战。
Hematology Am Soc Hematol Educ Program. 2012;2012:369-74. doi: 10.1182/asheducation-2012.1.369.
4
Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry.妊娠相关性获得性血友病 A：来自欧洲获得性血友病（EACH2）登记处的结果。
BJOG. 2012 Nov;119(12):1529-37. doi: 10.1111/j.1471-0528.2012.03469.x. Epub 2012 Aug 20.
5
Acquired inhibitors of coagulation factors: part I-acquired hemophilia A.获得性凝血因子抑制剂：第一部分-获得性血友病 A。
Semin Thromb Hemost. 2012 Jul;38(5):433-46. doi: 10.1055/s-0032-1315757. Epub 2012 Jun 27.
6
Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry.获得性血友病 A 出血的管理：来自欧洲获得性血友病（EACH2）登记处的结果。
Blood. 2012 Jul 5;120(1):39-46. doi: 10.1182/blood-2012-02-408930. Epub 2012 May 22.
7
Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).获得性血友病 A 的免疫抑制治疗：来自欧洲获得性血友病登记处（EACH2）的结果。
Blood. 2012 Jul 5;120(1):47-55. doi: 10.1182/blood-2012-02-409185. Epub 2012 Apr 18.
8
Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).获得性血友病 A 的人口统计学和临床数据：来自欧洲获得性血友病登记处（EACH2）的结果。
J Thromb Haemost. 2012 Apr;10(4):622-31. doi: 10.1111/j.1538-7836.2012.04654.x.
9
Management of acquired haemophilia A.获得性血友病 A 的治疗。
J Thromb Haemost. 2011 Jul;9 Suppl 1:226-35. doi: 10.1111/j.1538-7836.2011.04309.x.
10
[Long-term response to rituximab in a patient with acquired hemophilia].[利妥昔单抗对一名获得性血友病患者的长期疗效]
Rev Invest Clin. 2011 Mar-Apr;63(2):210-2.
Zotero 插件